Dopesick: 1x4

Video Sources 99 Views Report Error

WEBRIP

Pseudo-Addiction

Sky-high OxyContin sales are threatened by reports of abuse, prosecutors investigate a claim central to OxyContin marketing, and Finnix begins to question the safety of the drug.

Oct. 20, 2021

Shared0 Facebook Twitter

1 - 1
First Bottle Oct. 13, 2021
1 - 2
Breakthrough Pain Oct. 13, 2021
1 - 3
The 5th Vital Sign Oct. 13, 2021
1 - 4
Pseudo-Addiction Oct. 20, 2021
1 - 5
The Whistleblower Oct. 27, 2021
1 - 6
Hammer the Abusers Nov. 03, 2021
1 - 7
Black Box Warning Nov. 10, 2021
1 - 8
The People vs. Purdue Pharma Nov. 17, 2021

Login to your account

What's happening?

Video Sources 99 Views Report Error

Pseudo-Addiction